New drugs for tuberculosis: current status and future prospects.
Clin Chest Med
; 26(2): 327-40, vii, 2005 Jun.
Article
en En
| MEDLINE
| ID: mdl-15837114
This article reviews two classes of compounds that have advanced into phase II and III clinical trials, long-acting rifamycins and fluoroquinolones, and a number of other drugs that have entered or may enter clinical development in the near future.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Tuberculosis
/
Antituberculosos
Límite:
Humans
Idioma:
En
Revista:
Clin Chest Med
Año:
2005
Tipo del documento:
Article
País de afiliación:
Suiza